Carl P. Bergstrom - Concepedia

Author

Carl P. Bergstrom

Bristol-Myers Squibb (United States)

Also Known As

Bergstrom, Carl P., C P Bergstrom, Carl Bergstrom, Carl P Bergstrom, Carl P. Bergstrom

Publications

648

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University of Minnesota

About

Carl P. Bergstrom is an author at Bristol-Myers Squibb (United States) specializing in natural sciences, biochemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	8	8	347
2	Biochemistry	8	8	374
3	Medicine	7	7	340
4	Engineering	1	1	41
5	Biomolecular Engineering	1	1	41

Carl P. Bergstrom

Publications

617

Citations

H-Index

Page 1

	Year	Citations
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor Kevin W. Gillman, John E. Starrett, Michael F. Parker, ACS Medicinal Chemistry Letters Pharmaceutical SciencePharmacotherapyPharmaceutical ChemistryMedicinal ChemistryAlzheimer's Disease	2010	183
Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase Robert G. Gentles, Min Ding, John A. Bender, Journal of Medicinal Chemistry	2014	98
The Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression Catherine R. Burton, Jere E. Meredith, Donna M. Barten, Journal of Biological Chemistry	2008	66
Enantioselective Synthesis of (+)-Cyclophellitol R. H. Schlessinger, Carl P. Bergstrom The Journal of Organic Chemistry AltmetricsMolecular SciencesDonut IconMedicineInformation	1995	53
Overexpression and Large-Scale Purification of Recombinant Hamster Polymorphic ArylamineN-Acetyltransferase as a Dihydrofolate Reductase Fusion Protein Kristina R.K. Sticha, Christine A. Sieg, Carl P. Bergstrom, Protein Expression and Purification BiosynthesisCellular EnzymologyBiochemistryNatural SciencesProtein Biosynthesis	1997	45
Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus Xiaofan Zheng, Thomas W. Hudyma, Scott Martin, Bioorganic & Medicinal Chemistry Letters BiochemistryHepatitis C VirusViral HepatitisMedicinePolymerase Enzyme	2011	41
Diastereoselective Diels-Alder reactions of nonracemic 3- and 4-amino furans bound to polystyrene. A comparison of these reactions to their solution state analogues R. H. Schlessinger, Carl P. Bergstrom Tetrahedron Letters EngineeringAlkene MetathesisBiochemistry4-Amino Furanones 4Polymer 3	1996	41
Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer’s disease C. V. C. Prasad, Ming Zheng, Shikha Vig, Bioorganic & Medicinal Chemistry Letters Neurochemical BiomarkersTransgenic Mouse ModelAlzheimer ’Pharmaceutical ChemistryMolecular Pharmacology	2007	30
Characterization of Hamster Recombinant Monomorphic and Polymorphic Arylamine N-Acetyltransferases Kristina R.K. Sticha, Carl P. Bergstrom, Carston R. Wagner, Biochemical Pharmacology Natural SciencesMolecular BiologyHamster Recombinant MonomorphicChemical BiologyEnzymatic Modification	1998	16
The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors Scott Martin, Peter W. Glunz, Brett R. Beno, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineAntiviral Drug DevelopmentAntiviral TherapyNovel Class	2011	12

Page 1